The emergence of amphetamine use in New Zealand: Findings from the 1998 and 2001 National Drug Surveys

New Zealand Medical Journal

Volumn 115, Issue 1166, 2002, Pages

  Wilkins, Chris ^a   Bhatta, Krishna ^a   Casswell, Sally ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; ILLICIT DRUG; LYSERGIDE; METHAMPHETAMINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CHILD HEALTH; CIGARETTE SMOKING; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DRUG RESEARCH; DRUG USE; EMPLOYMENT; ENERGY; FAMILY LIFE; FINANCIAL MANAGEMENT; HEALTH HAZARD; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; NEW ZEALAND; PREVALENCE; PROSPECTIVE PRICING; SOCIAL LIFE; TELEPHONE; WELLBEING; DRUG ABUSE; FEMALE; INFORMATION PROCESSING; MALE;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; DATA COLLECTION; FEMALE; HUMANS; MALE; NEW ZEALAND; PREVALENCE;

EID: 0037160148     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. United Nations Drug Control Programme. World Drug Report 2001: United Nations Office for Drug Control and Crime Prevention. New York: Oxford, 2001.
2. United Nations Drug Control Programme. World Drug Report 2002: United Nations Office for Drug Control and Crime Prevention. New York: Oxford, 2002.
3. Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 2000-01. Canberra: Australian Bureau of Criminal Intelligence; 2002.
4. Matsumoto T, Kamijo A, Miyakawa T, et al. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 2002;97:809-17.
5. Sattah MV, Supawitkul S, Dondero TJ, et al. Prevalence of and risk factors for methamphetamine use in northern Thai youth: results of an audio-computer-assisted self-interviewing survey with urine testing. Addiction 2002;97:801-8.
6. Shearer J, Sherman J, Wodak A, van Beek I. Substitution therapy for amphetamine users. Drug Alcohol Rev 2002;21:179-85.
7. Kuhn C, Swartzwelder S, Wilson W. Buzzed: the straight facts about the most used and abused drugs from alcohol to ecstacy. New York: W.W.Norton & Co., 1998.
8. Gawin FH, Ellinwood EH. Cocaine and other stimulants. Actions, abuse and treatment. N Engl J Med 1988;318:1173-82.
9. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994;13:277-84.
10. Chesher G. Pharmacology of the sympathomimetic psychostimulants. In: Burrows D, Flaherty B, MacAvoy M, editors. Illicit psychostimulant use in Australia. Canberra: Australian Government Publishing Service, 1993. p. 9-30.
11. Wickes W. Medical aspects of psychostimulant use. In: Burrows D, Flaherty B, MacAvoy M, editors. Illicit psychostimulant use in Australia. Canberra: Australian Government Publishing Services, 1993. p. 31-52.
12. Zander B. Speed freaks. In: Listener, 6-12 April, 2002, 14-19.
13. Schmidt V. The energy and ecstasy. In: Metro, January 2001, 76-81.
14. Matthews P. The lost war on drugs. In: Listener, 19 May, 2001, 18-24.
15. Philp M. Gangland rising. In: Metro, June 2002, 34-45.
16. Darke S, Kaye S, Topp L. New South Wales drug trends 2001: findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2002.
17. Black, S, Casswell, S. Drugs in New Zealand. Auckland: Alcohol and Public Health Research Unit, University of Auckland, 1993.
18. McAuliffe W, Geller S, La Brie R, et al. Are telephone surveys suitable for studying substance abuse? Cost, administration, coverage and response rate issues. J Drug Issues 1998;28:455-82.
19. MacCoun R, Reuter P. Drug war heresies: learning from other vices, times, and places. New York: Cambridge University Press, 2001.
20. Hando J, Topp L, Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug Alcohol Depend 1997;46:105-13.
21. Baker A, Boggs T, Lewin T. Characteristics of regular amphetamine users and implications for treatment. Drug Alcohol Rev 2001;20:49-56.
22. New Zealand Police. Preliminary assessment of substance proposed for classification or reclassification under sections 4-4B of the Misuse of Drugs Act 1975 ("the Act") (Confidential). Wellington: New Zealand Police, 2002.
23. Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1999-2000. Canberra: Australian Bureau of Criminal Intelligence, 2001.
24. Newbold G. Crime in New Zealand. Palmerston North: Dunmore Press, 2000.
25. Wilkins CD. Cheating in retail drug transactions: theory and evidence. Department of Economics. Hamilton: University of Waikato, 1999.
26. Wilkins C, Casswell S. The cannabis black market and the case for the legalisation of cannabis in New Zealand. Social Policy Journal of New Zealand. 2002;18:31-43.
27. Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1996-97. Canberra: Australian Bureau of Criminal Intelligence; 1997.
28. United Nations Drug Control Programme. World Drug Report 2000: United Nations Office for Drug Control and Crime Prevention. New York: Oxford, 2000.
29. Australian Institute of Health and Welfare. 2001 National Drug Strategy Household Survey: first results. Canberra: Australian Institute of Health and Welfare, 2002.